Events

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 28th August, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker:  University of Auckland Associate Professor Cather Simpson - From Photon Factory to Dairy Biotechnology: pathway to Engender Technology

Cather Simpson is the Director of the University of Auckland's Photon factory, a high-tech laser research hub carrying out wide ranging projects from basic research to supporting industry in New Zealand and overseas through the development of new technologies.

In her talk Cather will discuss:

  • The work of the Photon factory and it's capabilities
  • Some case studies of high tech developments undertaken for companies
  • Research underpinning the formation of Engender Technologies: an Auckland Uniservices and Pacific Channel start up developing large scale parallel chip-based technology to sex sperm for the dairy industry.

"What we're doing is applying our problem analysis abilities and the ability of clever people to do cutting edge research in their own area of expertise at the same time. There is no doubt that advanced, high-tech science and engineering can add power to the New Zealand economy. We find it very rewarding to be part of that effort." (Cather Simpson)

RSVP
Please reply YES in the subject line be email.

Date and time
4.30-6:30pm drinks and canapes (for 5pm presentation), Friday 28th August, 2015.

Venue
reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds Str (see map)

Parking
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 24th July, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker:  Tony Dowd, CEO of Nelson-based Supreme Biotechnologies - The Supreme Biotech Story

Supreme Biotech is a private Nelson-based company producing bioactive compounds from micro algae. The company has been established in Nelson, largely because of the support and expertise available at the Cawthron Institute and the Nutrizeal extraction plant near Richmond. As you can see in the photos above, Supreme Biotech's 'plant' has large plastic tubes hang from the ceiling (pictured), filled with algae to produce astaxanthin - an extract said to be nature's most powerful antioxidant. The Cawthron Institute has helped the company develop prototypes, isolating a unique strain of algae, Haematococcus pluvialis, to produce high-quality astaxanthin, suitable for Supreme's purposes.

Tony will speak on the issues the company has had to face and solve (through-out the value chain) and also on what he sees the opportunities ahead to be.

RSVP - If you haven’t accepted the previously extended calendar invitation, and would like to attend, then please RSVP to Stephanie Tulloch on s.tulloch@auckland.ac.nz

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Thursday, 25th June, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker: Simon Wilkinson, Managing Director and CEO of Innate Immunotherapeutics

"If Survival = Success, then Innate Immunotherapeutics is doing OK!"

New Zealand biotech company Innate Immunotherapeutics has not only survived since it was founded in Auckland 15 years ago, but it is now only 45 patients away from a possible “really good day at the office”. At least that’s the assessment of Innate’s CEO and Managing Director, Simon Wilkinson.

Innate was ‘born’ Virionyx Corporation, a New Zealand unlisted public company, developing a passive immunotherapeutic for HIV patients without small molecule treatment options. The HIV programme was “put down” in 2008 and the company refocused on a second technology which is now in Phase 2B proof of platform trials in Australia and New Zealand. Along the way the Company shifted its legal (but not management and operational) residence to Australia and listed on the ASX following a successful IPO of A$10 million in late 2013.

As a former naval officer, banker, and now biotech CEO, Simon will give us his unique take on Douglas Adams’ (Hitchhiker's Guide to the Galaxy) quote “I may not have gone where I intended to go, but I think I have ended up where I needed to be”.

Cancel all other plans, reply “yes” now – and we’ll see you next Thursday, 25 June for a highly enjoyable evening!

RSVP Please reply YES by email

Date and time 4.30 pm (for 5 pm presentation), Thursday 25 June, 2015.

Venue - Reception Lounge, at the main entrance to the Thomas Building, 3a Symonds St (map attached).

Parking - University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 1 May, 2015
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speakers: Professor Peter Shepherd - An Overview of Drug Discovery and Development in New Zealand

I am more than delighted to welcome Professor Peter Shepherd as guest speaker to our Bioscience Enterprise Forum.

Google would have you believe that ‘Peter Shepherd’ is a Transformational Psychologist, British Army Doctor and/or the tetartagonist of the 1995 fantasy film, Jumanji. While Peter embodies all the best attributes of the aforementioned, he comes to us next week in his capacity as Professor of Cell Signalling in the University of Auckland’s Molecular Medicine & Pathology department and Honorary, Academic of the Auckland Cancer Society Research Centre.

Peter is an alumni of Massey University. He “postdoc-ed” at Harvard and Cambridge before joining the staff of University College London where he was promoted to Professor in 2003. There he became involved in biotechnology and was named London Young Biotechnology Entrepreneur of the Year in 2002.

Since moving back to Auckland in 2004 Peter has continued to focus on research of the signal transduction pathways in the cell and how defects in these lead to the development of cancer and diabetes.

In addition, Peter founded biotechnology company Symansis to develop novel tools for drug discovery, and was co- founder of drug development company Pathway Therapeutics.

Based in Auckland, but engaged in transnational collaborations worldwide, Peter is in a prime position to provide an overview of the translation of science from labs to health outcomes.

We’re very much looking forward to a great function and hope you will join us.

Please RSVP now and we’ll see you on Friday, 1 May.

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday, 27 February, 2015
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speakers: Dr Francis Hunter - Old target + Youthful talent = Spark-ling success
For this, our first monthly Forum for the year, we are delighted to welcome Dr Francis Hunter as guest speaker.

Francis is recently qualified for his PhD at the University of Auckland (congrats!), He is now establishing an R&D programme in New Zealand and the United States that may ultimately produce a new drug for pancreatic and other cancers.

Francis is also co-founder of Delaware-listed biopharmaceutical start-up company Mesopharm Therapeutics. Francis has been very active over a number of years in the University of Auckland’s excellent Spark Entrepreneurship Programme. Mesopharm Therapeutics was born out of Spark participation and in the wake of its young team’s stunning success at the inaugural International Breast Cancer Startup Challenge in Washington in March last year.

Francis has very recently returned from San Francisco after attending Onestart 2015’s Silicon Valley bootcamp. Here, Mesopharm execs received extensive mentorship from a top biopharma industry expert – in order to prepare and present business plans and company pitches to potential investors, industry partners and fellow entrepreneurs. Onestart 2015 (and here) is run by a bio-venture company, SR One and the Oxbridge Biotech Roundtable.

Cancel all other plans, RSVP now – and we’ll see you on Friday for a highly enjoyable evening!

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday12th December, 2014
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speakers: Quick-fire student presentations (60s max. from next year’s thesis students) and awards (Baldwins!), AND swords and champagne. Don’t miss this!

It’s be a very enjoyable celebration after a full on year. Thanks to all of you for your tremendous support!

As usual, from 4.30 – 6.30 in the Thomas Building. THIS coming Friday, 12 December.
No need to RSVP – just come along on Friday!


An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Wednesday 19th November, 2014
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker: Professor Juliet Gerrard - 'Engaging with Callaghan Innovation'
Juliet will speak particularly on her role as Callaghan Innovation’s Industry and Outreach Fellow.

Professor Juliet Gerrard is a highly regarded biochemist and leader in the industrial application of biochemistry in New Zealand. She holds a number of significant positions in recognition of her scientific work. In addition to her University of Auckland and Callaghan Innovation roles, these include Chair of the Marsden Council and Director of NZ Institute of Plant and Food Research.

The Industry and Outreach Fellowship was established by Callaghan Innovation’s predecessor IRL in order strengthen links between the research and high-value manufacturing organisations. Industry and Outreach Fellows are initially appointed for a five-year term and are mandated to resolve industry-related problems while building links between research institutions and business.

When she was appointed to this role, two years ago, Juliet said saw the overall strategic aim of the Industry and Outreach Fellowship programme as boosting collaboration. "There is a lot of research being done in both universities and industry and I’d like to bridge that gap between fundamental and applied work".

Two year’s into the role, we’ll hear how this Fellowship is relevant to the ever-evolving environment of science commercialisation. Don’t miss this opportunity to hear from one of New Zealand’s finest!

Please RSVP to Stephanie Tulloch.


An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday 17th October, 2014
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker: Francis Hunter: Experiences as an aspiring young scientist-entrepreneur

Francis Hunter is a Ph.D. student in Molecular Medicine and Pathology at the Auckland Cancer Society Research Centre, a long-serving contributor to the Spark Entrepreneurship Challenge and Co-Founder of a biopharmaceutical start-up company, where he is also Chief Scientific Officer in his spare time. His academic research investigates new paradigms in the management of cancer, whereby sophisticated novel drugs can be matched to patients whose disease profile greatly enhances the probability of a favourable clinical response.

In this presentation, Francis Hunter will describe his experiences as an early-career scientist-entrepreneur with a vision toward contributing to the establishment of a lucrative biopharmaceutical program in New Zealand. He will offer perspectives on how and why MBIE and other organisations should support aspiring young leaders.


An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday 29th August, 2014
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speaker: NZBIO CEO, Dr Will Barker - ‘From Breaking Bad to NZBIO’

Dr Will Barker has (very) recently been appointed as CEO of NZBIO.

Prior to joining NZBIO, Will spent 6 years as VP External Affairs at LanzaTech, where he led the global commercialisation activities. Those activities included: implementation of a market dominant patent strategy, negotiation and securing of high value partnerships with global Fortune 500 companies and closing financing transactions in excess of $100M.

Since arriving in NZ in 2000, Will has held Post-Doctoral research positions, investigated methamphetamine laboratories and had time to train as a registered patent attorney. Will’s PhD is in synthetic chemistry from the University of Leicester in the UK.

Come meet Will, next Friday, to hear about his very interesting career to date and aspirations for the future. Don’t miss out on a night of great company and conversation, with drinks and nibbles provided.

Stephanie Tulloch
Director Bioscience Enterprise Programme
Institute for Innovation in Biotechnology
Direct Dial +64 9 923 9625
Mobile +64 22 052 8171

Email director@bioscienterprise.ac.nz or s.tulloch@auckland.ac.nz


An invitation to a University of Auckland Bioscience Enterprise Friday Forum, sponsored by ATEED

Date: Friday 25th July, 2014
Time: 4:30pm networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences
Guest Speakers: Robert Feldman, Mike Bickerdike, Clive Seymour, and Helen Teale from Life Science New Zealand.

I am very pleased to announce this month that ATEED is the new Bioscience Enterprise Forum sponsor. ATEED (Auckland Tourism, Events and Economic Development) is the Auckland Council agency working to improve the economic prosperity of Auckland and, by association, New Zealand.

ATEED's support enables the Bioscience Enterprise programme to continue to offer the Forum to the Auckland bioscience community and we look forward to continuing a close and productive working relationship with ATEED. Many thanks to Mark Burgess, IIB Director, and Zahra Champion, ATEED, for making this happen.

Join the Bioscience Enterprise and ATEED team on Friday (details follow) for stimulating company, witty conversation, lovely food and wine AND a 15-20 minute presentation from:

Life Science New Zealand

Come celebrate the recent establishment of 'Life Science New Zealand', a grouping of four stellar industry professionals: Robert Feldman, Mike Bickerdike, Clive Seymour, and Helen Teale.

Robert, Mike, Clive and Helen bring highly complementary skills and expertise to the life science commercialisation process such that Life Science New Zealand is able to provide invaluable expertise across every stage of a life science venture's development (http://lifescience.co.nz).

Life Science New Zealand will share their story so far and vision for the future with us on Friday. Don't miss out!

I look forward to seeing you next Friday!

Best regards
Stephanie.

Stephanie Tulloch
Director Bioscience Enterprise Programme
Institute for Innovation in Biotechnology
University of Auckland